Canaccord Reiterates Buy Rating on STAAR Surgical (STAA)
Canaccord analyst John Young reiterated a Buy rating and $32.00 price target on STAAR Surgical (NASDAQ: STAA).The analyst commented: "STAAR ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
